Sonic Automotive Q4 2025 Earnings Preview

Seeking Alpha - Tue, 02/17/2026 - 11:19

Software Panic, Security Strength: Why Zscaler Still Wins

Seeking Alpha - Tue, 02/17/2026 - 11:17

Fanuc Roaring Back On Improving Industrial Sentiment

Seeking Alpha - Tue, 02/17/2026 - 11:16

Eagle Point Credit Company Inc. 6.75% PFD SR D declares $0.1406 dividend

Seeking Alpha - Tue, 02/17/2026 - 11:15

Gale-Force Winds Will Test Fair-Weather Sailors

Seeking Alpha - Tue, 02/17/2026 - 11:13

Leidos targets up to 4% revenue growth in 2026 as NorthStar 2030 strategy gains traction

Seeking Alpha - Tue, 02/17/2026 - 11:12

GSK: Post-Pivot Buoyancy Set To Continue After Strong 2025 (Upgrade)

Seeking Alpha - Tue, 02/17/2026 - 11:10

Wall Street is muted as investors come back from holiday

Seeking Alpha - Tue, 02/17/2026 - 11:08

AI Fears Play Whack-A-Mole Within The Market

Seeking Alpha - Tue, 02/17/2026 - 11:08

Affirm: The Stock Keeps Dropping, Free Cash Flow Jumps Higher

Seeking Alpha - Tue, 02/17/2026 - 11:08

IAT: Undervalued Regional Banks With Strong Growth Momentum

Seeking Alpha - Tue, 02/17/2026 - 11:06

Twist Bioscience rises on licensing deal for antibody discovery platform

Seeking Alpha - Tue, 02/17/2026 - 11:05

Teva Pharmaceutical Industries Limited (TEVA) Discusses Duvakitug IBD Phase 2b Maintenance Top-Line Results - Slideshow

Seeking Alpha - Tue, 02/17/2026 - 11:02

ICL Group Q4 2025 Earnings Preview

Seeking Alpha - Tue, 02/17/2026 - 10:56

Hafnia Limited: Well-Integrated Shipping Giant Offering Attractive Investor Yield

Seeking Alpha - Tue, 02/17/2026 - 10:56

Genuine Parts Company outlines plan to separate automotive and industrial businesses targeting Q1 2027 completion

Seeking Alpha - Tue, 02/17/2026 - 10:55

Top 10 bullish Infotech stocks with highest year-over-year capex growth

Seeking Alpha - Tue, 02/17/2026 - 10:55

Palantir confirms it has moved headquarters to Florida from Colorado

Seeking Alpha - Tue, 02/17/2026 - 10:54

Clean Harbors Q4 2025 Earnings Preview

Seeking Alpha - Tue, 02/17/2026 - 10:49

CRISPR Therapeutics Q4: The Elite Time To Buy Is In 2027

Seeking Alpha - Tue, 02/17/2026 - 10:49

Pages